Idexx (IDXX) Reports Q4 Earnings: What Key Metrics Have to Say

Core Insights - Idexx Laboratories reported revenue of $954.29 million for the quarter ended December 2024, reflecting a year-over-year increase of 5.8% and exceeding the Zacks Consensus Estimate of $936.78 million by 1.87% [1] - The company's EPS for the quarter was $2.62, up from $2.32 in the same quarter last year, surpassing the consensus EPS estimate of $2.40 by 9.17% [1] Financial Performance Metrics - Gross Profit - CAG: 59.7% versus the two-analyst average estimate of 59% [4] - Gross Profit - Other: 34.6% versus the two-analyst average estimate of 21.1% [4] - Gross Profit - LPD: 49.6% compared to the 55.7% average estimate based on two analysts [4] - Gross Profit - Water: 72.4% versus the two-analyst average estimate of 68.8% [4] Revenue Breakdown - Revenue from the Companion Animal Group in the United States was $574.10 million, exceeding the two-analyst average estimate of $564.74 million, with a year-over-year change of +4.4% [4] - Revenue from the Companion Animal Group Internationally was $296.37 million, surpassing the two-analyst average estimate of $286.18 million, with a year-over-year change of +9.2% [4] - Revenue from Livestock and Poultry Diagnostics (LPD) Internationally was $28.15 million, compared to the $25.71 million average estimate, representing a year-over-year change of +1.1% [4] - Revenue from Water Internationally was $23.14 million, slightly below the $23.49 million average estimate, with a year-over-year change of +5.7% [4] - Total revenue from the Companion Animal Group (CAG) was $870.47 million, exceeding the five-analyst average estimate of $854.04 million, with a year-over-year change of +6% [4] - Revenue from Other was $4.11 million, below the $5.80 million estimated by five analysts, representing a year-over-year decline of -28.7% [4] - Revenue from Livestock and Poultry Diagnostics (LPD) was $34.56 million, exceeding the $31.09 million average estimate, with a year-over-year change of +5.4% [4] - Revenue from Water was $45.15 million, slightly below the five-analyst average estimate of $45.63 million, with a year-over-year change of +8.1% [4] Stock Performance - Idexx shares returned +1.6% over the past month, compared to the Zacks S&P 500 composite's +2.7% change, indicating potential underperformance in the near term with a Zacks Rank 4 (Sell) [3]